Inhibition of pleomorphism by protein and ribonucleic acid inhibitors.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001375:Azaguanine / Q000494:pharmacology*; D002701:Chloramphenicol / Q000494:pharmacology; D003470:Culture Media; D003513:Cycloheximide / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D003857:Deoxyuridine / Q000494:pharmacology*; D008937:Mitomycins / Q000494:pharmacology; D009154:Mutation; D014176:Protein Biosynthesis; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis; D013997:Time Factors; D014249:Trichophyton / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism
D000900:Anti-Bacterial Agents; D003470:Culture Media; D008937:Mitomycins; D003609:Dactinomycin; D011691:Puromycin; D012313:RNA; D002701:Chloramphenicol; D004247:DNA; D003513:Cycloheximide; D001375:Azaguanine; D003857:Deoxyuridine